China Biotech Finance Watch: Luzhu Bags $43.5m In Hong Kong IPO

funding
Luzhu Biotech became the first biotech in 2023 to complete an IPO in Hong Kong • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia